lirentelimab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for lirentelimab, covering 2024-01-02 to 2024-04-18. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) [Phase 3]